Related Experiment Video
Updated: Apr 20, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.5K
Performance-based financial incentives for diabetes care: an effective strategy?
Lesley P Latham1, Emily Gard Marshall1
1Dalhousie University, Halifax, Nova Scotia, Canada.
Canadian Journal of Diabetes
|December 3, 2014
Summary
Financial incentives for primary care physicians show mixed results for diabetes care. Evidence suggests caution is needed, as systemic barriers, not just physician behavior, impact patient outcomes.
Area of Science:
- Health Services Research
- Primary Care Medicine
- Diabetes Management
Background:
- Financial incentives are proposed to improve adherence to diabetes care recommendations.
- Implementing these models in universal healthcare systems presents unique challenges.
Purpose of the Study:
- To explore characteristics of physician incentive models for diabetes care.
- To assess the success of these interventions in improving diabetes outcomes.
- To identify challenges and concerns associated with incentive program implementation.
Main Methods:
- Comparative analysis of incentive models in the UK, Australia, Taiwan, and Canada.
- Review of evidence on the efficacy of financial incentives in primary care settings.
Main Results:
- UK studies show some improvements in process outcomes and achievement of cholesterol, blood pressure, and glycated hemoglobin (A1C) targets.
- Limited evidence outside the UK suggests participating physicians may have already provided guideline-recommended care.
- Pay-for-performance models may impact professionalism and patient-centered care.
Conclusions:
- Definitive evidence that financial incentives improve primary care diabetes management quality is lacking.
- Policymakers should exercise caution and consider systemic barriers beyond physician behavior.
- Addressing factors hindering patient-physician partnership in diabetes management is crucial.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetic Nephropathy
2
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
2
Diabetes Mellitus: Introduction
2
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
2
Diabetic Retinopathy
11
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
11
Diabetes Mellitus: Type 2 and Gestational
5.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.9K
Health Information Technology and Healthcare Information System
3.7K
Health Information Technology (HIT)
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
Health Information Technology, commonly called HIT, integrates advanced information systems and technology in healthcare settings. Its primary functions include:
3.7K

